CorMedix (CRMD) News Today $13.61 +0.03 (+0.22%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$13.58 -0.02 (-0.18%) As of 06/20/2025 07:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRMD Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period CorMedix (NASDAQ:CRMD) Earns "Outperform" Rating from Royal Bank Of CanadaRoyal Bank Of Canada restated an "outperform" rating and issued a $17.00 target price (up previously from $13.00) on shares of CorMedix in a report on Friday.June 20 at 10:42 AM | marketbeat.comCorMedix Inc.'s (NASDAQ:CRMD) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?June 19 at 11:11 AM | finance.yahoo.comWealth Enhancement Advisory Services LLC Trims Position in CorMedix Inc. (NASDAQ:CRMD)Wealth Enhancement Advisory Services LLC trimmed its stake in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) by 40.5% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 31,045 shares of the company's stock after selling 21,139 shares durJune 16, 2025 | marketbeat.comCorMedix Inc. (NASDAQ:CRMD) Receives Average Recommendation of "Buy" from AnalystsCorMedix Inc. (NASDAQ:CRMD - Get Free Report) has been assigned a consensus rating of "Buy" from the seven analysts that are covering the company, MarketBeat.com reports. Six investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the coJune 15, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Hits New 12-Month High - Should You Buy?CorMedix (NASDAQ:CRMD) Hits New 12-Month High - Here's WhyJune 12, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Reaches New 12-Month High - Still a Buy?CorMedix (NASDAQ:CRMD) Hits New 52-Week High - What's Next?June 6, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Stock Price Up 6.9% - Time to Buy?CorMedix (NASDAQ:CRMD) Trading 6.9% Higher - Should You Buy?June 5, 2025 | marketbeat.comCorMedix: DefenCath In Exponential Growth Phase With Robust Market PositionJune 5, 2025 | seekingalpha.comCorMedix: Exceeding ExpectationsJune 4, 2025 | seekingalpha.comMillennium Management LLC Has $1.44 Million Holdings in CorMedix Inc. (NASDAQ:CRMD)Millennium Management LLC boosted its position in CorMedix Inc. (NASDAQ:CRMD - Free Report) by 97.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 178,134 shares of the company's stock after buying an additional 87,896June 4, 2025 | marketbeat.comCorMedix Inc. To Participate In The Jefferies Global Healthcare ConferenceMay 30, 2025 | globenewswire.comNorthern Trust Corp Purchases 64,243 Shares of CorMedix Inc. (NASDAQ:CRMD)Northern Trust Corp raised its position in CorMedix Inc. (NASDAQ:CRMD - Free Report) by 14.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 511,565 shares of the company's stock after buying an additional 64,243 shares during the period. Northern TrMay 25, 2025 | marketbeat.comPalisades Investment Partners LLC Makes New Investment in CorMedix Inc. (NASDAQ:CRMD)Palisades Investment Partners LLC purchased a new stake in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 364,019 shares of the company's stock,May 24, 2025 | marketbeat.comCorMedix at RBC Capital Markets: Strategic Expansion and GrowthMay 23, 2025 | investing.comCorMedix Inc. (NASDAQ:CRMD) Given Consensus Recommendation of "Buy" by AnalystsCorMedix Inc. (NASDAQ:CRMD - Get Free Report) has been given an average recommendation of "Buy" by the seven brokerages that are covering the stock, Marketbeat reports. Six research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the companMay 23, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Buys 125,425 Shares of CorMedix Inc. (NASDAQ:CRMD)D. E. Shaw & Co. Inc. raised its stake in CorMedix Inc. (NASDAQ:CRMD - Free Report) by 39.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 446,414 shares of the company's stock after purchasing an additionMay 21, 2025 | marketbeat.comBalyasny Asset Management L.P. Makes New Investment in CorMedix Inc. (NASDAQ:CRMD)Balyasny Asset Management L.P. acquired a new position in CorMedix Inc. (NASDAQ:CRMD - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 44,270 shares of the company's stock, valued at approximately $35May 19, 2025 | marketbeat.comCubist Systematic Strategies LLC Purchases New Stake in CorMedix Inc. (NASDAQ:CRMD)Cubist Systematic Strategies LLC purchased a new stake in CorMedix Inc. (NASDAQ:CRMD - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 72,354 shares of the company's stoMay 18, 2025 | marketbeat.comNicholas Investment Partners LP Takes Position in CorMedix Inc. (NASDAQ:CRMD)Nicholas Investment Partners LP bought a new stake in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 94,132 shares of the company's stock, valued atMay 17, 2025 | marketbeat.comVoya Investment Management LLC Lowers Stock Position in CorMedix Inc. (NASDAQ:CRMD)Voya Investment Management LLC lowered its position in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) by 97.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 17,658 shares of the company's stock after selling 721,401May 17, 2025 | marketbeat.comCorMedix Inc. to Participate in the RBC Global Healthcare ConferenceMay 15, 2025 | globenewswire.comJ. Goldman & Co LP Boosts Stake in CorMedix Inc. (NASDAQ:CRMD)J. Goldman & Co LP boosted its stake in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) by 221.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 457,320 shares of the company's stock after buying aMay 14, 2025 | marketbeat.comWhat is Leerink Partnrs' Estimate for CorMedix Q2 Earnings?CorMedix Inc. (NASDAQ:CRMD - Free Report) - Research analysts at Leerink Partnrs upped their Q2 2025 earnings per share estimates for CorMedix in a research note issued on Tuesday, May 6th. Leerink Partnrs analyst R. Ruiz now anticipates that the company will earn $0.14 per share for the quarter,May 11, 2025 | marketbeat.comElliott Investment Management L.P. Buys 1,320,109 Shares of CorMedix Inc. (NASDAQ:CRMD)Elliott Investment Management L.P. lifted its stake in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) by 85.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,870,632 shares of theMay 11, 2025 | marketbeat.comWhat is Leerink Partnrs' Forecast for CorMedix Q3 Earnings?CorMedix Inc. (NASDAQ:CRMD - Free Report) - Leerink Partnrs reduced their Q3 2025 earnings estimates for CorMedix in a research note issued on Tuesday, May 6th. Leerink Partnrs analyst R. Ruiz now expects that the company will earn $0.13 per share for the quarter, down from their previous forecasMay 10, 2025 | marketbeat.comCorMedix Inc. (CRMD): Among Billionaire Paul Singer’s Stock Picks with Huge Upside PotentialMay 10, 2025 | finance.yahoo.comNeedham & Company LLC Issues Positive Forecast for CorMedix (NASDAQ:CRMD) Stock PriceNeedham & Company LLC increased their target price on CorMedix from $12.00 to $15.00 and gave the stock a "buy" rating in a research report on Wednesday.May 9, 2025 | marketbeat.comCorMedix Inc. (CRMD): Among Billionaire Paul Singer’s Stock Picks with Huge Upside PotentialMay 9, 2025 | insidermonkey.comBarclays PLC Purchases 27,732 Shares of CorMedix Inc. (NASDAQ:CRMD)Barclays PLC raised its position in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) by 35.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 105,602 shares of the company's stock after purchasingMay 9, 2025 | marketbeat.comAnalysts Just Shipped A Substantial Upgrade To Their CorMedix Inc. (NASDAQ:CRMD) EstimatesMay 8, 2025 | finance.yahoo.comCorMedix Inc. (NASDAQ:CRMD) Q1 2025 Earnings Call TranscriptMay 8, 2025 | insidermonkey.comCorMedix (NASDAQ:CRMD) Receives Buy Rating from D. Boral CapitalD. Boral Capital reaffirmed a "buy" rating and set a $15.00 price objective on shares of CorMedix in a research note on Tuesday.May 8, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Releases Quarterly Earnings ResultsCorMedix (NASDAQ:CRMD - Get Free Report) issued its earnings results on Tuesday. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.25 by $0.05. During the same period last year, the business posted ($0.25) earnings per share.May 8, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Shares Gap Up Following Better-Than-Expected EarningsCorMedix (NASDAQ:CRMD) Shares Gap Up After Earnings BeatMay 8, 2025 | marketbeat.comRaymond James Financial Inc. Buys Shares of 115,661 CorMedix Inc. (NASDAQ:CRMD)Raymond James Financial Inc. bought a new position in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 115,661 shares of the company's stock, valuMay 8, 2025 | marketbeat.comEarnings call transcript: CorMedix Q1 2025 results beat expectations, stock risesMay 7, 2025 | uk.investing.comCorMedix Inc. Reports Q1 2025 Financial Results: $39.1 Million in Net Revenue and Positive Adjusted EBITDA of $23.6 MillionMay 7, 2025 | nasdaq.comCorMedix Inc.May 7, 2025 | wsj.comCormedix Inc (CRMD) Q1 2025: Everything You Need To Know Ahead Of EarningsMay 7, 2025 | finance.yahoo.comCormedix Inc (CRMD) Q1 2025 Earnings Call Highlights: Record Profitability and Strategic Growth ...May 7, 2025 | finance.yahoo.comCorMedix, Inc.: CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 6, 2025 | finanznachrichten.deCorMedix stock rises as Q1 earnings and revenue surpass estimatesMay 6, 2025 | investing.comCorMedix Q1 Earnings Trump Estimates: Retail’s OverjoyedMay 6, 2025 | msn.comCorMedix stock rises after earnings, revenue beatMay 6, 2025 | msn.comCorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update | CRMD ...May 6, 2025 | gurufocus.comCorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 6, 2025 | gurufocus.comCorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 6, 2025 | globenewswire.comRenaissance Technologies LLC Makes New $1.09 Million Investment in CorMedix Inc. (NASDAQ:CRMD)Renaissance Technologies LLC purchased a new stake in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 134,000 shares of the company'May 3, 2025 | marketbeat.comCorMedix (CRMD) Expected to Announce Earnings on TuesdayCorMedix (NASDAQ:CRMD) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-cormedix-inc-stock-1/)May 3, 2025 | marketbeat.comCorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025April 29, 2025 | globenewswire.com Get CorMedix News Delivered to You Automatically Sign up to receive the latest news and ratings for CRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address CRMD Media Mentions By Week CRMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRMD News Sentiment▼0.790.66▲Average Medical News Sentiment CRMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRMD Articles This Week▼54▲CRMD Articles Average Week Get CorMedix News Delivered to You Automatically Sign up to receive the latest news and ratings for CRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies KRYS News ACAD News MRUS News RNA News ACLX News SWTX News RARE News PTGX News SRRK News KYMR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRMD) was last updated on 6/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredThe IRS Loophole That Lets You Own Gold Tax-FreeWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorMedix Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share CorMedix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.